Metsera Inc (MTSR) Actualités

Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership

Metsera Announces Closing of Initial Public Offering and Full Exercise and Closing of Underwriters’ Option to Purchase Additional Shares

NEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Metsera, Inc. (Nasdaq: MTSR) (“Metsera”), a clinical-stage biotechnology company developing...

Form S-8 - Securities to be offered to employees in employee benefit plans

Metsera Announces Pricing of Initial Public Offering

NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Metsera, Inc. (Nasdaq: MTSR) (“Metsera”), a clinical-stage biotechnology company developing...